Jose L. Lopez-Ribot

Publications

• Addition of DNase Improves the in Vitro Activity of Antifungal Drugs Against Candida Albicans Biofilms
  Mycoses. Jan, 2012  |   Pubmed ID: 21668524
• Sodium Hypochlorite, Chlorhexidine Gluconate, and Commercial Denture Cleansers As Disinfecting Agents Against Candida Albicans: An in Vitro Comparison Study
  General Dentistry. Nov, 2011  |   Pubmed ID: 22313927
• Effect of Exogenous Administration of Candida Albicans Autoregulatory Alcohols in a Murine Model of Hematogenously Disseminated Candidiasis
  Journal of Basic Microbiology. Nov, 2011  |   Pubmed ID: 22052380
• Hsp90 Governs Dispersion and Drug Resistance of Fungal Biofilms
  PLoS Pathogens. Sep, 2011  |   Pubmed ID: 21931556
• Validation of the Tetracycline Regulatable Gene Expression System for the Study of the Pathogenesis of Infectious Disease
  PloS One. 2011  |   Pubmed ID: 21633704
• Effects of Fluconazole, Amphotericin B, and Caspofungin on Candida Albicans Biofilms Under Conditions of Flow and on Biofilm Dispersion
  Antimicrobial Agents and Chemotherapy. Jul, 2011  |   Pubmed ID: 21518839
• An Easy and Economical in Vitro Method for the Formation of Candida Albicans Biofilms Under Continuous Conditions of Flow
  Virulence. Nov-Dec, 2010  |   Pubmed ID: 21178492
• The Transcriptional Regulator Nrg1p Controls Candida Albicans Biofilm Formation and Dispersion
  Eukaryotic Cell. Oct, 2010  |   Pubmed ID: 20709787
• Dispersion As an Important Step in the Candida Albicans Biofilm Developmental Cycle
  PLoS Pathogens. Mar, 2010  |   Pubmed ID: 20360962
• Presence of Extracellular DNA in the Candida Albicans Biofilm Matrix and Its Contribution to Biofilms
  Mycopathologia. May, 2010  |   Pubmed ID: 20012895
• Characteristics of Candida Albicans Biofilms Grown in a Synthetic Urine Medium
  Journal of Clinical Microbiology. Dec, 2009  |   Pubmed ID: 19794044
• Treatment and Prevention of Candida Albicans Biofilms with Caspofungin in a Novel Central Venous Catheter Murine Model of Candidiasis
  The Journal of Antimicrobial Chemotherapy. Sep, 2009  |   Pubmed ID: 19584104
• Adhesion of Candida Albicans to Endothelial Cells Under Physiological Conditions of Flow
  Infection and Immunity. Sep, 2009  |   Pubmed ID: 19581400
• Design of a Simple Model of Candida Albicans Biofilms Formed Under Conditions of Flow: Development, Architecture, and Drug Resistance
  Mycopathologia. Sep, 2009  |   Pubmed ID: 19370400
• Efficacy of a Genetically Engineered Candida Albicans Tet-NRG1 Strain As an Experimental Live Attenuated Vaccine Against Hematogenously Disseminated Candidiasis
  Clinical and Vaccine Immunology : CVI. Mar, 2009  |   Pubmed ID: 19144791
• Expression Levels of a Filament-specific Transcriptional Regulator Are Sufficient to Determine Candida Albicans Morphology and Virulence
  Proceedings of the National Academy of Sciences of the United States of America. Jan, 2009  |   Pubmed ID: 19116272
• Effect of Tunicamycin on Candida Albicans Biofilm Formation and Maintenance
  The Journal of Antimicrobial Chemotherapy. Mar, 2009  |   Pubmed ID: 19098294
• A Simple and Reproducible 96-well Plate-based Method for the Formation of Fungal Biofilms and Its Application to Antifungal Susceptibility Testing
  Nature Protocols. 2008  |   Pubmed ID: 18772877
• Candida Albicans-endothelial Cell Interactions: a Key Step in the Pathogenesis of Systemic Candidiasis
  Infection and Immunity. Oct, 2008  |   Pubmed ID: 18573891
• A Seed and Feed Model for the Formation of Candida Albicans Biofilms Under Flow Conditions Using an Improved Modified Robbins Device
  Revista Iberoamericana De Micología : órgano De La Asociación Española De Especialistas En Micología. Mar, 2008  |   Pubmed ID: 18338926
• UME6, a Novel Filament-specific Regulator of Candida Albicans Hyphal Extension and Virulence
  Molecular Biology of the Cell. Apr, 2008  |   Pubmed ID: 18216277
• Use of a Genetically Engineered Strain to Evaluate the Pathogenic Potential of Yeast Cell and Filamentous Forms During Candida Albicans Systemic Infection in Immunodeficient Mice
  Infection and Immunity. Jan, 2008  |   Pubmed ID: 17967861
• Inhibition on Candida Albicans Biofilm Formation Using Divalent Cation Chelators (EDTA)
  Mycopathologia. Dec, 2007  |   Pubmed ID: 17909983
• Proteomics to Study Candida Albicans Biology and Pathogenicity
  Infectious Disorders Drug Targets. Dec, 2006  |   Pubmed ID: 17168799
• A Proteomic-based Approach for the Identification of Candida Albicans Protein Components Present in a Subunit Vaccine That Protects Against Disseminated Candidiasis
  Proteomics. Nov, 2006  |   Pubmed ID: 17051645
• Biofilm Formation by Candida Albicans Mutants for Genes Coding Fungal Proteins Exhibiting the Eight-cysteine-containing CFEM Domain
  FEMS Yeast Research. Nov, 2006  |   Pubmed ID: 17042757
• Inhibition of Filamentation Can Be Used to Treat Disseminated Candidiasis
  Antimicrobial Agents and Chemotherapy. Oct, 2006  |   Pubmed ID: 17005810
• Proteomics for the Analysis of the Candida Albicans Biofilm Lifestyle
  Proteomics. Nov, 2006  |   Pubmed ID: 17001605
• Drosophila Melanogaster As a Facile Model for Large-scale Studies of Virulence Mechanisms and Antifungal Drug Efficacy in Candida Species
  The Journal of Infectious Diseases. Apr, 2006  |   Pubmed ID: 16518764
• A Role for Efg1p in Candida Albicans Interactions with Extracellular Matrices
  FEMS Microbiology Letters. Mar, 2006  |   Pubmed ID: 16487333
• Use of Genome Information for the Study of the Pathogenesis of Fungal Infections and the Development of Diagnostic Tools
  Revista Iberoamericana De Micología : órgano De La Asociación Española De Especialistas En Micología. Dec, 2005  |   Pubmed ID: 16499417
• Candida Albicans Biofilms: More Than Filamentation
  Current Biology : CB. Jun, 2005  |   Pubmed ID: 15964263
• Candida Biofilms: an Update
  Eukaryotic Cell. Apr, 2005  |   Pubmed ID: 15821123
• Denture Stomatitis: a Role for Candida Biofilms
  Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. Jul, 2004  |   Pubmed ID: 15243471
• Antibody Response to Candida Albicans Cell Wall Antigens
  FEMS Immunology and Medical Microbiology. Jul, 2004  |   Pubmed ID: 15196567
• Inducible Defense Mechanism Against Nitric Oxide in Candida Albicans
  Eukaryotic Cell. Jun, 2004  |   Pubmed ID: 15189992
• Caspofungin Resistance in Candida Albicans: Correlating Clinical Outcome with Laboratory Susceptibility Testing of Three Isogenic Isolates Serially Obtained from a Patient with Progressive Candida Esophagitis
  Antimicrobial Agents and Chemotherapy. Apr, 2004  |   Pubmed ID: 15047549
• The C-terminal Antibody Binding Domain of Candida Albicans Mp58 Represents a Protective Epitope During Candidiasis
  FEMS Microbiology Letters. Mar, 2004  |   Pubmed ID: 15033231
• Changes in Susceptibility to Posaconazole in Clinical Isolates of Candida Albicans
  The Journal of Antimicrobial Chemotherapy. Jan, 2004  |   Pubmed ID: 14657086
• Antifungal Combinations Against Candida Albicans Biofilms in Vitro
  Antimicrobial Agents and Chemotherapy. Nov, 2003  |   Pubmed ID: 14576141
• Engineered Control of Cell Morphology in Vivo Reveals Distinct Roles for Yeast and Filamentous Forms of Candida Albicans During Infection
  Eukaryotic Cell. Oct, 2003  |   Pubmed ID: 14555488
• Inhibition of Candida Albicans Biofilm Formation by Farnesol, a Quorum-sensing Molecule
  Applied and Environmental Microbiology. Nov, 2002  |   Pubmed ID: 12406738
• In Vitro Pharmacodynamic Properties of Three Antifungal Agents Against Preformed Candida Albicans Biofilms Determined by Time-kill Studies
  Antimicrobial Agents and Chemotherapy. Nov, 2002  |   Pubmed ID: 12384379
• In Vitro Activity of Caspofungin Against Candida Albicans Biofilms
  Antimicrobial Agents and Chemotherapy. Nov, 2002  |   Pubmed ID: 12384370
• The Filamentation Pathway Controlled by the Efg1 Regulator Protein is Required for Normal Biofilm Formation and Development in Candida Albicans
  FEMS Microbiology Letters. Aug, 2002  |   Pubmed ID: 12204378
• Replacement of Candida Albicans with C. Dubliniensis in Human Immunodeficiency Virus-infected Patients with Oropharyngeal Candidiasis Treated with Fluconazole
  Journal of Clinical Microbiology. Sep, 2002  |   Pubmed ID: 12202543
• Investigation of Multidrug Efflux Pumps in Relation to Fluconazole Resistance in Candida Albicans Biofilms
  The Journal of Antimicrobial Chemotherapy. Jun, 2002  |   Pubmed ID: 12039889
• In Vitro Activity of Caspofungin (MK-0991) Against Candida Albicans Clinical Isolates Displaying Different Mechanisms of Azole Resistance
  Journal of Clinical Microbiology. Jun, 2002  |   Pubmed ID: 12037093
• Molecular Mechanisms of Fluconazole Resistance in Candida Dubliniensis Isolates from Human Immunodeficiency Virus-infected Patients with Oropharyngeal Candidiasis
  Antimicrobial Agents and Chemotherapy. Jun, 2002  |   Pubmed ID: 12019078